| Virksomhedsstatus | | NORMAL. |
| Sidst opdateret den 09.02.2015 og
angivet som gældende fra 01.01.1999 (9454
dage). |
Ingen historik.
| Branche | | Fremstilling af plast i ubearbejdet form (201600). |
| Sidst opdateret den 23.12.2007 og
angivet som gældende fra 01.01.2008 (6167
dage). |
| Historik | Start | Stop |
|---|
| Fremstilling af plast i ubearbejdet form (201600) | 01.01.2008 | |
| Fremstilling af basisplast (241600) | 01.01.2003 | 31.12.2007 |
| Fremstilling af farmaceutiske råvarer (244100) | 21.07.2000 | 31.12.2002 |
| Fremstilling af stivelse og stivelsesprodukter (156200) | 01.01.1999 | 20.07.2000 |
| Revisionfravalgt | | false. |
| Sidst opdateret den 11.03.2015 og
angivet som gældende fra 01.01.1999 (9454
dage). |
Ingen historik.
| Kontaktoplysninger | | invoice.cph@cytiva.com. |
| Sidst opdateret den 07.06.2023 og
angivet som gældende fra 07.06.2023 (531
dage). |
| Historik | Start | Stop |
|---|
| invoice.cph@cytiva.com | 07.06.2023 | |
| info.copenhagen@lonza.com | 29.10.2008 | 06.06.2023 |
| Telefonnummer | | 43567400. |
| Sidst opdateret den 19.05.2003 og
angivet som gældende fra 08.05.2003 (7866
dage). |
| Historik | Start | Stop |
|---|
| 43567400 | 08.05.2003 | |
| 43567400 | 21.05.2001 | 21.12.2002 |
| Navne | | Cytiva Denmark Manufacturing ApS. |
| Sidst opdateret den 05.08.2022 og
angivet som gældende fra 05.08.2022 (837
dage). |
| Historik | Start | Stop |
|---|
| Cytiva Denmark Manufacturing ApS | 05.08.2022 | |
| LONZA COPENHAGEN ApS | 08.02.2007 | 04.08.2022 |
| CAMBREX BIO SCIENCE COPENHAGEN ApS | 14.10.2002 | 07.02.2007 |
| BIOWHITTAKER MOLECULAR APPLICATIONS ApS | 10.07.1999 | 13.10.2002 |
| ApS KBIL 38 NR. 2238 | 01.01.1999 | 09.07.1999 |
| Tegningsregel | | Selskabet tegnes af bestyrelsesformanden, af to medlemmer af bestyrelsen i forening eller af den samlede bestyrelse. |
| Sidst opdateret den 05.08.2022 og
angivet som gældende fra 05.08.2022 (837
dage). |
| Fortolkning
(3 tegningsmuligheder)
| | formanden |
| 2 bestyrelsesmedlemmer + |
| bestyrelsen |
| Historik | Start | Stop |
|---|
| Selskabet tegnes af bestyrelsesformanden, af to medlemmer af bestyrelsen i forening eller af den samlede bestyrelse | 05.08.2022 | |
| Selskabet tegnes af to bestyrelsesmedlemmer i forening | 11.01.2011 | 04.08.2022 |
Type af revisorbistand:Auditor's report on audited financial statements
Navn på revisionsvirksomhed:EY Godkendt Revisionspartnerselskab
Revisionsvirksomhedens CVR-nr.:30700228
Beskrivelse af revisor:State Authorised Public Accountant
Virksomhedens regnskabsklasse:Reporting class B
Grundlag for konklusion (revision):Basis for opinion We conducted our audit in accordance with International Standards on Auditing (ISAs) and additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the "Auditor's responsibilities for the audit of the financial statements" section of our report. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Konklusion (revision):Opinion We have audited the financial statements of Cytiva Denmark Manufacturing ApS for the financial year 1 January – 31 December 2023, which comprise income statement, balance sheet, statement of changes in equity and notes, including accounting policies. The financial statements are prepared in accordance with the Danish Financial Statements Act. In our opinion, the financial statements give a true and fair view of the financial position of the Company at 31 December 2023 and of the results of the Company's operations for the financial year 1 January – 31 December 2023 in accordance with the Danish Financial Statements Act.
Udtalelse om ledelsesberetningen (revision):Statement on the Management's review Management is responsible for the Management's review. Our opinion on the financial statements døs not cover the Management's review, and we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the Management's review and, in doing so, consider whether the Management's review is materially inconsistent with the financial statements or our knowledge obtained during the audit, or otherwise appears to be materially misstated. Moreover, it is our responsibility to consider whether the Management's review provides the information required under the Danish Financial Statements Act. Based on the work we have performed, we conclude that the Management's review is in accordance with the financial statements and has been prepared in accordance with the requirements of the Danish Financial Statements Act. We did not identify any material misstatement of the Management's review.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
Ingen nuværende registrering.
Ingen historik.
LoginOpret gratis brugere-conomic integration